Novartis said that the latest round of job losses is a result of a change in focus for its cardiovascular teams as they lower the emphasis on Entresto and devote more resources to its twice-yearly ...

EnteroBiotix's IBS trial is the company's second to suggest there is value in the approach, coming a few months after the ...

AstraZeneca has agreed to acquire Belgian in vivo cell therapy biotech EsoBiotec, strengthening its position in the emerging ...

Central rebates amounted to £631 million in England in 2023/24. This explains the headline stat of a £19.9bn spend on ...

Novo Nordisk became only the eighth company to be suspended from the ABPI in its 40-year history for several transgressions, the most serious of which was a breach of Clause 2 of the code, deemed to ...

By identifying friction points and translating them into actionable insights, CX teams help ensure innovation is grounded in real user needs, rather than assumptions. They prevent businesses from ...

Through a pioneering initiative called Chronos-PD, Grifols is partnering with the Michael J. Fox Foundation for Parkinson’s ...

Join us at the 4th Targeted Radiopharmaceuticals Summit US, returning to San Diego this July, as the largest end-to-end, ...

The Japanese pharma company – currently in the process of rolling out new amyloid-targeting Alzheimer's therapy Leqembi ...

The 4th World ADC Asia Summit is back, offering the most comprehensive platform for Asia’s rapidly growing ADC community. This summit brings together cutting-edge innovators from Asia alongside ...

Nevertheless, the rise in the Statutory Scheme rate to almost a third of pharma company revenue – which brings the average ...

Latigo Biotherapeutics has tapped into investor interest in pain relief medicines with new, non-opioid mechanisms of action, ...